Gluvoiz PM 1mg/500mg/15mg Tablet
Marketer
Voizmed Pharma Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Gluvoiz PM 1mg/500mg/15mg Tablet
Diabetic patients may find relief with the combined-action Gluvoiz PM 1mg/500mg/15mg tablet, a formulation designed to regulate blood glucose. This medication, when used as directed alongside a balanced diet and regular exercise program, assists adults with type 2 diabetes in managing their blood sugar. Its mechanism enhances insulin effectiveness, thus reducing elevated blood glucose. Always adhere to your physician's prescribed dosage and duration for Gluvoiz PM 1mg/500mg/15mg tablets. Ingestion with food is recommended to mitigate gastrointestinal discomfort. If a dose is missed, take it promptly; however, near the time of the next scheduled dose, omit the missed dose and resume the usual regimen. Never double the dose. Excessive intake may result in hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is crucial. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Individuals with kidney, liver, or heart conditions must disclose this information to their doctor prior to commencing treatment. Pregnant or lactating women should consult their doctor before use. Kidney function assessment will be performed before treatment initiation. Minimize alcohol consumption to lessen potential side effects.
Uses of Gluvoiz PM 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Gluvoiz PM 1mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Gluvoiz PM 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Gluvoiz PM 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Gluvoiz PM 1mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Gluvoiz PM 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
How Gluvoiz PM 1mg/500mg/15mg Tablet works:
Gluvoiz PM 1mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts via reduced hepatic glucose production, slowed intestinal glucose absorption, and enhanced insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gluvoiz PM 1mg/500mg/15mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Gluvoiz PM 1mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Gluvoiz PM 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Gluvoiz PM 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Gluvoiz PM 1mg/500mg/15mg tablets, as dose modification may be necessary. Individuals with severe hepatic dysfunction should avoid this medication; physician consultation is advised.
What if you forget to take Gluvoiz PM 1mg/500mg/15mg Tablet :
Should you forget a Gluvoiz PM 1mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gluvoiz PM 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently